Company Active LTD

Company profile

Biolauncher Limited

Biolauncher Limited is a UK company with status active founded in 2001 based in South East England.

CRN
04172118
Founded
2001
Age
25

Overview

Legal name
BIOLAUNCHER LIMITED
Region
South East England
Registered address
UNIT 8B BANKSIDE HANBOROUGH BUSINESS PARK
LONG HANBOROUGH
WITNEY
ENGLAND
OX29 8LJ
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Biolauncher Limited
CRN 04172118
2
Direct and ultimate controller Active LTD
Precisionlife Ltd
CRN 08687703

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
0

Company events

Reference milestones and recent Companies House filing stream events.

5 events
19 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

05 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

05 Mar
2001

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2011
Funded years
2011, 2012
Age at first award
10 years

Projects

2012 Collaborative R&D Lead participant

Demonstrating an innovative End-to-End Drug Discovery (E2D2) platform

1 Aug 2012 to 31 Oct 2014

Awarded
£45,961
Total cost £93,283

The E2D2 project will develop and demonstrate novel technologies combined in an integrated approach that identifies active medicinal drugs by exploiting Omics information. By developing technologies to link together the platforms of three UK SMEs, E2D2 will enable an information-led platform approach for drug discovery, delivering novel active drug compou...

2011 GRD Proof of Concept Lead participant

From Target to Drug

1 Oct 2011 to 30 Jun 2012

Awarded
£55,000
Total cost £91,749

This project aims to develop a proof-of-concept of a key enabling technology that can deliver a step change in the speed and cost of discovering new candidate drugs. The project will develop innovative bioinformatics technologies that can link two principal platforms of modern drug discovery: large scale peptide screening and synthetic chemistry of small ...

2011 Collaborative R&D

Exploiting data for drug reprofiling

1 Aug 2011 to 30 Sep 2012

Awarded
£121,532
Total cost £202,553

The project aims to create a platform through which the partners are able to offer products and services to customers in the area of drug re-profiling or re-purposing. Re-profiling generally consists of looking for a new therapeutic application for an existing drug molecule, or stated another way, searching databases of known drug molecules to find compou...

Product types

Collaborative R&D GRD Proof of Concept